In partnership with
November 25, 2025
Built by a former cannabis regulator, Policy, Decoded helps operators read the policy terrain before it shifts beneath their feet.
Today we move through a week shaped by a federal court decision that unsettles long-standing firearms rules for cannabis consumers, a set of state reactions to the hemp crackdown that reveal how uneven the system has become, and early signals from FDA about where it plans to place its enforcement weight. Minnesota is preparing for the possibility that its hemp beverage economy may not survive the shutdown deal, Tennessee is carving out a narrow lane for legacy shops, and federal agencies are reviewing the gun ruling that now sits in conflict with other circuits. Psychedelics policy adds its own momentum from New Jersey to the lab bench, and municipal leaders in Minnesota are testing whether cities should take retail into their own hands.
Today’s edition is supported by AG1 and Morning Brew. Their support keeps this free for you and worth it for me.
🔫 A federal gun ruling exposes a fractured legal terrain
🥤 States reposition as the hemp crackdown reshapes local economies
📡 FDA signals a tighter band of enforcement against high-risk products
A new Thanksgiving episode of The Hybrid is out this morning with a side dish draft that rewards anyone who likes smart debates about food and policy in equal measure.
Good days start with clarity.
The daily health habit you’ll actually stick with…
This time of year, it’s SO hard to stay in control of your health.
Holiday travel (and meals!), big family gatherings, dark and cold days, it’s easy to skip that workout, sleep in later than you should, or have just one more cookie.
That’s why you need a daily health habit that’s easy to stick with.
Meet AG1: With just one quick scoop every morning, you’ll get over 75 ingredients that help support your immune health, gut health, energy, and close nutrient gaps in your diet.
Right now is the best time to get started - with every new subscription, they are giving away $126 in free gifts for the holidays.
Give AG1 a try today and take control of your health this holiday season.
Start here — the day’s most important development, decoded for impact.
📌 What Happened: Federal judges in the Fifth Circuit just threw out a firearms conviction after concluding that the underlying crime of being a marijuana user with a gun failed the Second Amendment test. In the case of Kevin LaMarcus Mitchell, the court held that the federal “unlawful user” statute, 18 U.S.C. § 922(g)(3), could not support a permanent firearm ban based only on his admission of habitual cannabis use without proof that he was intoxicated when he possessed the gun. Applying the Bruen history-and-tradition framework, the panel found no historical analogue for disarming a person indefinitely on the basis of ongoing marijuana use and directed that Mitchell’s conviction and sentence be vacated. The decision extends a line of Fifth Circuit cases that have already narrowed or invalidated § 922(g)(3) in as-applied challenges from cannabis consumers. It arrives in a landscape where other federal appellate courts have reached different conclusions or insisted on case-by-case analysis for “unlawful users,” which has deepened doctrinal confusion. The Marijuana Moment report frames this latest ruling as another clear sign that the statute is under real constitutional strain.
💡 Why It Matters: The same legal question is already on the Supreme Court’s docket in United States v. Hemani, a Fifth Circuit case involving a marijuana and cocaine user where justices agreed in October to decide whether § 922(g)(3) violates the Second Amendment as applied. The Mitchell ruling gives the Court fresh evidence of how that provision operates in practice, including its tendency to convert past or routine cannabis use into a lifelong bar on gun rights. At the same time, courts in the Tenth and Eleventh Circuits have either dismissed indictments or ruled for state-legal marijuana patients on similar grounds, while the Third Circuit has pushed district judges toward individualized judgments rather than blanket approval or rejection. That mix of outcomes amounts to the kind of “multi-sided and growing circuit conflict” the Justice Department itself flagged in Hemani and virtually guarantees a nationwide answer from the justices. Until that opinion lands, cannabis consumers will live in a patchwork where gun possession that is a felony in one circuit can be constitutionally protected in another. Federal prosecutors and ATF will also need to decide how aggressively to pursue “unlawful user” cases in regions where appellate courts are already skeptical.
🧠 THC Group Take: The core problem is that Congress built § 922(g)(3) for a world in which “drug user” meant something closer to a chronic public-safety risk, and the statute never caught up to state-legal cannabis programs that treat millions of patients and consumers as ordinary participants in civic life (because they are). Background check forms and ATF guidance still tell those people that a truthful admission about marijuana use can cost them their gun rights, yet federal courts are now dividing over whether that consequence fits the Constitution at all. The Fifth Circuit’s approach, which ties disarmament to proof of actual intoxication or concrete danger rather than status alone, aligns more closely with the way states have historically regulated guns around alcohol use. Other circuits have signaled that they may tolerate § 922(g)(3) in narrower applications, which sets the stage for the Supreme Court to decide whether to prune the statute, uphold it, or invite Congress to redesign it. No matter which path the Court chooses, cannabis regulators and licensees should expect more patients asking whether enrollment in a state program can be used as evidence of “unlawful use,” and those agencies will continue to have almost no ability to give definitive comfort. Somewhere in this mix is a veteran, a medical cardholder, or a rural hunter who thought they were following the rules and now sits at the center of a constitutional fight that never appeared on the ballot when their state legalized.
Fast-moving headlines, flagged for what matters.
Minnesota’s “low-dose” hemp beverage experiment, once held up as a model, is now staring at a federal provision that would cap hemp products at 0.4 milligrams of THC per container, a level that effectively wipes out the state’s current drink market. Brewers, bottle shops, and hemp manufacturers tell local reporters that THC seltzers have become a lifeline in a crowded craft beer landscape, often accounting for double-digit shares of store and taproom revenue. Trade groups and retailers describe the shutdown deal language as an existential threat to a sector that has poured tens of millions into production, branding, and co-packing capacity since 2022. The one-year implementation delay buys time for lobbying, but it also freezes long-term planning as operators weigh whether to invest, pivot, or prepare for a wind-down. The episode captures how quickly a permissive state framework can be undercut when federal lawmakers decide a “loophole” has grown too large to ignore. (Twin Cities Business)
A House Republican argued that Senate Republicans put veterans at risk when they stripped medical cannabis access provisions from this year’s VA funding package. He pointed to years of bipartisan work that aimed to let VA physicians discuss and recommend medical cannabis in states where it is legal, noting that the current prohibition leaves veterans navigating care without their primary clinicians. He warned that the Senate’s move undercuts a growing coalition inside the GOP that views cannabis as a legitimate therapeutic option for pain and PTSD. The remarks come as veteran service organizations push for clearer federal guidance and as VA leadership signals a willingness to study cannabis but remains constrained by statute. The dispute shows how internal GOP dynamics can complicate incremental reforms even when the constituency is unified. (Marijuana Moment)
A new Vicente analysis of FDA warning letters makes clear that the agency still treats all consumable hemp cannabinoids as technically unlawful, yet reserves its real enforcement energy for a tight band of products it views as dangerous or deceptive. Over the past two years, FDA and FTC have focused on delta-8 copycat snacks that mimic kids’ cereals and candies, unapproved drug claims for human and animal products, and high-risk dosage forms like CBD eye drops and intravenous preparations. The letters show a coordinated posture: FDA invokes adulterated food and unapproved drug theories while FTC leans on unfair and deceptive marketing, especially where packaging targets children. Animal CBD products now sit squarely in the crosshairs, with FDA warning that cannabinoids in food-producing animals raise downstream questions about meat and dairy safety. For hemp and beverage operators, the through line is simple: if your product looks like a snack for kids, behaves like a drug, or rides a novel route of administration, you are volunteering for federal attention in a world where everything is already technically out of bounds. (Vicente LLP)
Regulators and hemp advocates have reached a deal that will let some Tennessee retailers keep selling THCA flower and related products even as a new law banning them comes online. The agreement carves out breathing room for “legacy” hemp businesses that already hold Department of Agriculture licenses, while cutting off convenience and grocery outlets that had jumped in more recently. Industry lawyers warn that roughly three-quarters of the existing THCA market will still fall on the wrong side of the new statute once the compromise runs its course. Oversight of hemp products is shifting from Agriculture to the Alcoholic Beverage Commission, which brings a different enforcement culture and a track record of tight control over age-restricted products. For operators who survive the transition, the message is clear: this is not a reprieve for the category so much as an early filter for who gets to stand in the new, narrower lane. (Tennessee Lookout)
Courts and regulators continue to pull labor peace requirements in different directions, leaving operators to navigate rules that rarely settle long enough to plan around them. A federal judge in California dismissed a challenge to the state’s mandate after framing cannabis illegality as a barrier for plaintiffs, even though data show only a fraction of active licensees have filed LPAs. Oregon took a different path when a federal court struck down its mandate as preempted by the NLRA, prompting the OLCC to pause enforcement and rethink its approach. New York and New Jersey now sit in the middle of active litigation, while Connecticut and Rhode Island keep their mandates intact with little clarity about long-term enforcement. Operators with footprints across these states will face uneven conditions and a steady need for tailored labor strategies that depend on venue rather than principle. (Seyfarth Shaw LLP via JD Supra)
Osseo approved plans to open what could be Minnesota’s first municipally owned cannabis dispensary in 2026, with Voyageur Cannabis Services handling operations in a renovated former newspaper building. City leaders are selling the concept as a way to capture profit for taxpayers, yet the model turns the municipality into both rule taker and market player in a town that will also host a private retailer. Local government will now answer for pricing, inventory decisions, and hiring in a sector where political pressure tends to arrive faster than revenue. Private operators watching this move will see a precedent for cities that prefer owning the margin rather than simply regulating it. If the experiment sours, it will strengthen arguments that cannabis policy already asks too much of local government and should leave retail risk to the private sector. (MJBizDaily)
Regulators in Hawaii quietly broadened what medical dispensaries can stock this month, clearing the way for dry herb vaporizers, rolling papers, grinders, and other paraphernalia to be sold alongside existing products. New rules from the Department of Health’s Office of Medical Cannabis Control and Regulation also clarify that oils and concentrates are not limited to the “edible” bucket and can be marketed for inhalation if they meet ingredient restrictions like no nicotine and no hemp-derived cannabinoids. The package codifies caregiver access inside dispensaries, tightens advertising rules, and bars shops from doubling as certification hubs for in-person or telehealth recommendations, which keeps a cleaner line between medical practice and retail. Combined with recent moves on caregiver plant counts, hemp product registration, and expungement reforms, Hawaii is slowly tuning its medical framework while adult-use legalization keeps stalling in the Legislature. The new rules give operators more realistic tools to serve patients and signal how OMCCR may approach form factors and retail boundaries if the state ever moves to a broader market. (Marijuana Moment)
Lawmakers in Trenton have approved legislation to create a regulated psilocybin therapy program for adults with qualifying health conditions, pushing the bill deeper into the 2026 session calendar. The Assembly Health Committee reported the measure out favorably after testimony from patients and veterans, aligning the bill with a Senate companion that dropped earlier language for general adult-use possession. The proposal would task the Department of Health with licensing five categories of psilocybin operators, overseeing a Psilocybin Advisory Board, and setting clinical protocols for preparation, administration, and integration sessions. A social equity framework is built in, including technical assistance, reduced fees, and financial support to make services accessible for low-income patients. If enacted, the program will test how far New Jersey can build psychedelic health infrastructure under federal prohibition and anchor it in a tightly supervised clinical model. (Marijuana Moment)
A new political economy analysis argues that psychedelic companies keep colliding with a basic truth of the field: the experience itself carries too much subjectivity for standard pharmaceutical control. The paper tracks five major firms through a rush of investment, a string of high expectations around FDA breakthrough designations, and a comedown shaped by weak trial results and the agency’s rejection of MDMA for PTSD. Investors who once treated psychedelics as a predictable frontier now face products that rely on human interpretation as much as chemistry. That tension shows up in states working to build clinical programs around natural psychedelics, where the rules look more like therapy frameworks than drug pipelines. For cannabis and hemp executives who watch adjacent markets for cues, the financial pattern feels familiar and points to slower paths wherever the science and the marketing drift out of sync. (Ganjapreneur)
Brazil’s national agricultural research agency, Embrapa, has secured Anvisa’s approval to run a 12-year cannabis research program, including a seed bank and large-scale cultivation trials. Researchers plan to adapt genetics for Brazil’s climate, study hemp for fiber, and map out future production hubs in a country that already dominates global soy and corn exports. The move nudges Brazil toward formal cannabis cultivation even as recreational use remains illegal and medical rules stay narrow. International cannabis firms are already circling, with several approaching Embrapa about research partnerships before any commercial grow is authorized. If the program follows the playbook that turned Brazil into an agricultural superpower, the long game points to a low-cost, high-volume player waiting in the wings of the global cannabis supply chain. (Ganjapreneur)
State prosecutors in Michigan charged a 52-year-old man from Macomb Township with multiple felonies for running what they describe as an unlicensed marijuana operation that brought in more than $1 million in sales without remitting a dollar in taxes. Investigators say he sold cannabis products at a Chesterfield Township shop and via online orders for years, all while falsely suggesting the business was compliant with Michigan’s regulated system. The Attorney General’s office is leaning on tax and fraud counts, including failure to file returns and using a computer to commit a crime, which carry potential prison time and significant financial penalties. Officials are framing the case as a warning shot to gray-market operators who use the trappings of legitimacy to undercut licensed retailers. For compliant businesses already squeezed by wholesale prices and new taxes, this kind of prosecution doubles as a signal that the state is finally willing to treat “shadow retail” as economic crime instead of a regulatory misunderstanding. (The Detroit News)
Consider this our entire pitch:
Morning Brew isn’t your typical business newsletter — mostly because we actually want you to enjoy reading it.
Each morning, we break down the biggest stories in business, tech, and finance with wit, clarity, and just enough personality to make you forget you’re reading the news. Plus, our crosswords and quizzes are a dangerously fun bonus — a little brain boost to go with your morning coffee.
Join over 4 million readers who think staying informed doesn’t have to feel like work.
From the hearing room to the comment section — we’re watching it all.
🎰 Heading to MJBiz next week like everybody else? Vegas side rooms are filling up with brand founders, investors, and operators trading deals long before the expo floor opens. Conversations move fastest in the quiet corners where golf carts and rooftop suites double as meeting rooms. (Cannabis & Tech Today)
🌿 A small guild of “Ganjiers” is building a shared language for cannabis quality, borrowing cues from wine and coffee to score aroma, texture, flavor, and effect with more discipline than THC labels allow. Their work is showing up in retail training, bud-bar service, and global judging circuits, giving craft growers a way to stand out in markets dominated by discounts. Source: Cannabis Industry Journal